Major histocompatibility complex abnormalities in non-Hodgkin lymphomas

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Radioimmunotherapy of non-Hodgkin lymphomas.

Enthusiasm for the use of monoclonal antibodies, such as rituximab, has markedly changed the approach to patients with non-Hodgkin lymphomas (NHLs). Nevertheless, more effective therapies are needed. Radioimmunotherapy as a form of targeted radiation therapy may add significantly to our therapeutic options. Yttrium Y 90 ibritumomab tiuxetan, recently approved by the Food and Drug Administration...

متن کامل

The major histocompatibility complex.

The major histocompatibility complex on the sixth chromosome controls expression of a complex series of cell surface antigens which comprise the human leukocyte antigen (HLA) system. These markers, beyond their importance in human organ transplantation, have been demonstrated to occur with an increased prevalence in certain disease states. The group of conditions showing the closest association...

متن کامل

Porcine major histocompatibility complex.

The major histocompatibility complex in swine (swine leucocyte antigen: SLA) is located on chromosome 7 with the class I and class III regions separated by the centromere from the class II region. The overall molecular organisation of the class I and III regions is well known, but further research is needed to establish that of the class II region. Approximately sixty genes have been characteri...

متن کامل

Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas.

Paraneoplastic neurological syndromes (PNSs) rarely associate with Hodgkin lymphoma (HL) and non-HLs (NHLs). Except for paraneoplastic cerebellar degeneration (PCD) in HL and dermato/ polymyositis in both HL and NHL, other PNSs are uncommon and have only been reported as isolated case reports or short series. There are several important differences in PNSs when occurring in association with HL ...

متن کامل

Shifting Treatment Paradigms in Non-hodgkin Lymphomas

Disclosure: Prof Caballero has served as a member of advisory boards and participated in educational activities for Bristol-Myers Squibb, Celgene, Janssen, Kite, Nordic, and Roche. Prof Vitolo has received research grants and served as principal investigator in studies sponsored by Celgene and Roche; he received sponsorship for speaking engagements at conferences and educational activities from...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: British Journal of Haematology

سال: 2002

ISSN: 0007-1048

DOI: 10.1046/j.1365-2141.2002.03814.x